Zirconium Hydride Catalysis Initiated by Tetrabutylammonium Fluoride

Area of Science:

• Organic Chemistry
• Catalysis
• Medicinal Chemistry

Background:

• Targeting oncogenic drivers in cancer requires efficient synthesis of complex molecules.
• Chiral benzylamines are crucial intermediates in drug discovery and natural product synthesis.
• Existing synthetic methods often lack chemoselectivity, stereoselectivity, or cost-effectiveness.

Purpose of the Study:

• To develop a novel catalytic method for the chemoselective and stereoselective synthesis of chiral benzylamines.
• To establish an economical and practical reduction strategy using readily available zirconium catalysts.
• To explore the utility of this methodology in synthesizing key intermediates for drug discovery.

Main Methods:

• Development of a catalytic zirconium hydride reduction using zirconocene dichloride.
• Utilized a novel tetrabutylammonium fluoride (TBAF) activation strategy to generate the active metal hydride.
• Performed reactions under ambient conditions, demonstrating practicality and ease of use.

Main Results:

• Successfully synthesized chiral benzylamines with high diastereoselectivity and chemoselectivity.
• Demonstrated the method's effectiveness with sulfinyl ketimines and carbonyl compounds relevant to medicinal chemistry.
• Preliminary mechanistic studies suggest zirconocene fluoride formation initiates the catalytic cycle.

Conclusions:

• The developed zirconium hydride reduction offers a selective, economical, and convenient route to chiral benzylamines.
• The TBAF activation tactic provides a practical means to generate active zirconium hydrides.
• This methodology holds potential for broader applications of zirconium hydrides in catalytic organic synthesis.